Navigation Links
FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of the neuroimmune axis and its role in disease processes. The importance of the neuroimmune axis in disease pathophysiology and therapies will be discussed for benchmark nervous system disorders, such as multiple sclerosis and spinal cord injury.

In addition, emerging areas where the importance of the neuroimmune axis has only recently been recognized, such as neuropsychiatric disorders, lysosomal storage diseases and axonal regeneration will be discussed. This FASEB Conference brings together physician-scientists and basic scientists as well as postdoctoral and graduate trainees for presentations and one-on-one discussions to broaden our understanding of fundamental aspects of disease mechanisms and therapeutic strategies in a highly collaborative and collegial environment.

A new training component associated with this conference will include a one day pre-meeting course on neuroimmunology, with material crafted to coincide with the major scientific topics covered during the main meeting. The interdisciplinary nature of this conference arises from an understanding that neuroimmune processes are intimately linked to the pathophysiology of numerous nervous system disorders, and through understanding the cellular and molecular mechanisms of these pathologies, more effective therapies may be realized. The conference is attended by immunologists, neuroscientists, neuroimmunologists, physicians and physician-scientists and is the only long-standing specialized conference held in North America to regularly attract members from each of these related, but distinct disciplines.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
2. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
3. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
4. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
5. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
6. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
7. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
8. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
9. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
10. FASEB announces BioArt image and video competition winners
11. MARC travel awards announced for the July 2013 FASEB Science Research Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology: